Cynosure, a leader in medical aesthetics systems and technologies, announced it has appointed Nadav Tomer, an accomplished medical technology executive and former operating advisor to funds affiliated with Cynosure investor Clayton, Dubilier & Rice (CD&R), as Cynosure’s chief executive officer, effective May 1, 2023. He succeeds Todd Tillemans, who will step down as chief executive officer and will…
Tag: Todd Tillemans
Cynosure appoints Sujat Sukthankar as Executive VP of Research & Product Development
by
•Cynosure, the global leader in medical aesthetics and develops, manufactures and markets aesthetic treatment systems has announced the appointment of Sujat Sukthankar, former VP of Platform Engineering at Becton Dickinson and Vice President of R&D at Boston Scientific, as the Company’s Executive Vice President of Research & Product Development, effective immediately. In this new role,…